SRTS

MKT CAP:$67M

Sensus Healthcare, Inc.

Market Cap

$67M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$4.01-$0.09 (-2.20%)

Apr 21, 2026

Company Details

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of t...

CEO

Joseph C. Sardano

IPO Date

Jul 26, 2016

Website

www.sensushealthcare.com

Key Metrics TTM

Revenue

$34M

-18.5% YoY

Net Income

-$5M

EPS (Diluted)

-$0.32

Free Cash Flow

-$2M

Revenue / Share

$2.06

Gross Margin

48.3%

Operating Margin

-17.9%

Net Margin

-15.5%

FCF Margin

-7.0%

P/S

2.0x

P/E

—

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Mar 4, 2026

$27M-34.3%EPS -$0.47

Q4 2025

Mar 4, 2026

$5M-62.2%EPS -$0.19

Q2 2025

Aug 12, 2025

$7M-20.8%EPS -$0.06

Q1 2025

May 15, 2025

$8M-21.7%EPS -$0.16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$13M	$9M	$5M
Q1 22	$10M	$7M	$4M
Q2 22	$12M	$8M	$5M
Q3 22	$9M	$6M	$2M
Q4 22	$13M	$8M	$4M
Q1 23	$3M	$2M	-$3M
Q2 23	$5M	$3M	-$1M
Q3 23	$4M	$2M	-$2M
Q4 23	$13M	$8M	$6M
Q1 24	$11M	$7M	$3M
Q2 24	$9M	$5M	$2M
Q3 24	$9M	$5M	$1M
Q4 24	$13M	$7M	$2M
Q1 25	$8M	$4M	-$3M
Q2 25	$7M	$3M	-$2M
Q4 25	$5M	$2M	-$3M

Valuation

Quarter	P/S	P/E
Q4 21	2.5x	16.1x
Q1 22	1.9x	3.1x
Q2 22	1.6x	2.6x
Q3 22	1.5x	2.5x
Q4 22	1.5x	2.7x
Q1 23	1.8x	10.6x
Q2 23	2.2x	27.9x
Q3 23	2.7x	—
Q4 23	2.7x	137.1x
Q1 24	2.1x	14.3x
Q2 24	1.8x	10.0x
Q3 24	1.6x	7.1x
Q4 24	1.6x	10.0x
Q1 25	1.7x	36.9x
Q2 25	1.8x	—
Q4 25	2.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	-$2M	-$2M
Q1 22	$3M	$3M
Q2 22	$2M	$2M
Q3 22	$4M	$4M
Q4 22	-$10M	-$10M
Q1 23	-$6M	-$6M
Q2 23	$742.0K	$713.0K
Q3 23	$442.0K	$431.0K
Q4 23	$3M	$3M
Q1 24	-$8M	-$8M
Q2 24	$4M	$4M
Q3 24	$4M	$4M
Q4 24	-$827.0K	-$530.0K
Q1 25	-$3M	-$3M
Q2 25	$3M	$3M
Q4 25	-$2M	-$2M

Capital Expenditures

Quarter	CapEx
Q4 21	$38.0K
Q1 22	$44.0K
Q2 22	$45.0K
Q3 22	$60.0K
Q4 22	$10.0K
Q1 23	$189.0K
Q2 23	$29.0K
Q3 23	$11.0K
Q4 23	$0
Q1 24	$233.0K
Q2 24	$3.0K
Q3 24	$337.0K
Q4 24	$297.0K
Q1 25	$7.0K
Q2 25	$27.0K
Q4 25	$41.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+155.7%	+59.3%
Q1 22	+236.7%	+53.1%
Q2 22	+122.8%	+31.7%
Q3 22	+63.1%	+28.5%
Q4 22	+0.6%	+15.9%
Q1 23	-67.0%	-0.9%
Q2 23	-62.5%	-24.7%
Q3 23	-56.7%	-15.4%
Q4 23	-4.1%	-21.8%
Q1 24	+212.3%	+22.4%
Q2 24	+104.1%	+28.4%
Q3 24	+126.8%	+26.8%
Q4 24	+4.0%	+62.3%
Q1 25	-21.7%	+41.3%
Q2 25	-20.8%	+27.6%
Q4 25	-44.1%	+10.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$90.0K	0.7%
Q1 22	$57.0K	0.6%
Q2 22	$40.0K	0.3%
Q3 22	$40.0K	0.4%
Q4 22	$50.0K	0.4%
Q1 23	$143.0K	4.2%
Q2 23	$66.0K	1.5%
Q3 23	$67.0K	1.7%
Q4 23	$52.0K	0.4%
Q1 24	$91.0K	0.9%
Q2 24	$65.0K	0.7%
Q3 24	$45.0K	0.5%
Q4 24	$122.0K	0.9%
Q1 25	$79.0K	0.9%
Q2 25	$67.0K	0.9%
Q4 25	$76.0K	1.5%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 21	$1M	$1M	$1M
Q1 22	$728.0K	$1M	$1M
Q2 22	$827.0K	$1M	$2M
Q3 22	$746.0K	$1M	$2M
Q4 22	$1M	$1M	$2M
Q1 23	$1M	$1M	$2M
Q2 23	$822.0K	$1M	$2M
Q3 23	$1M	$2M	$1M
Q4 23	$678.0K	$949.0K	$625.0K
Q1 24	$926.0K	$2M	$1M
Q2 24	$866.0K	$2M	$996.0K
Q3 24	$863.0K	$2M	$1M
Q4 24	$2M	$2M	$1M
Q1 25	$3M	$2M	$2M
Q2 25	$1M	$2M	$1M
Q4 25	$2M	$2M	$1M

Revenue Segments

Quarter	Product	Service	Product Revenue	Service Revenue
Q1 24	$9M	$799.0K	—	—
Q1 25	$7M	$624.0K	$199.0K	$813.0K
Q2 25	$5M	$726.0K	$358.0K	$841.0K
Q4 25	$3M	$559.0K	$634.0K	$918.0K

Revenue by Geography

Quarter	China	Other Member	United States	Guatemala	Ireland	Israel	Other
Q3 22	$594.0K	$9.0K	$8M	—	—	—	—
Q4 22	$968.0K	$64.0K	$12M	—	—	—	—
Q1 23	$130.0K	$10.0K	$3M	—	—	—	—
Q2 23	$300.0K	$10.0K	$4M	$190.0K	$135.0K	—	—
Q4 23	$611.0K	$15.0K	$12M	—	—	—	—
Q1 24	$155.0K	$29.0K	$10M	—	—	—	—
Q2 24	$572.0K	$29.0K	$9M	—	—	—	—
Q3 24	$6.0K	$3.0K	$9M	—	—	$141.0K	—
Q4 24	$712.0K	—	$12M	—	—	$31.0K	—
Q1 25	$176.0K	—	$8M	—	—	—	$17.0K
Q2 25	$587.0K	—	$7M	—	—	—	$16.0K
Q4 25	$811.0K	—	$4M	—	—	—	$22.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$33M	$0	$33M
Q2 22	$34M	$0	$34M
Q3 22	$38M	$0	$38M
Q4 22	$26M	$0	$26M
Q1 23	$19M	$0	$19M
Q2 23	$20M	$0	$20M
Q3 23	$20M	$0	$20M
Q4 23	$23M	$0	$23M
Q1 24	$15M	$0	$15M
Q2 24	$19M	$0	$19M
Q3 24	$23M	$0	$23M
Q4 24	$22M	$0	$22M
Q1 25	$19M	$0	$19M
Q2 25	$22M	$0	$22M
Q3 25	$24M	$0	$24M
Q4 25	$22M	$0	$22M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	17M	+0.6%	+0.9%
Q1 22	17M	+0.2%	+1.1%
Q2 22	17M	-0.1%	+1.1%
Q3 22	17M	-0.2%	+0.6%
Q4 22	17M	-0.1%	-0.1%
Q1 23	16M	-2.0%	-2.4%
Q2 23	16M	+0.0%	-2.3%
Q3 23	16M	+0.1%	-2.0%
Q4 23	16M	+0.0%	-1.8%
Q1 24	16M	+0.3%	+0.4%
Q2 24	16M	+0.1%	+0.5%
Q3 24	16M	+0.1%	+0.5%
Q4 24	16M	+0.6%	+1.0%
Q1 25	16M	-0.5%	+0.3%
Q2 25	16M	-0.2%	-0.1%
Q4 25	16M	+0.0%	-0.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$352.0K	37
Q1 22	$279.4K	37
Q2 22	$326.5K	37
Q3 22	$243.5K	37
Q4 22	$312.0K	42
Q1 23	$81.3K	42
Q2 23	$107.8K	42
Q3 23	$92.8K	42
Q4 23	$359.0K	35
Q1 24	$304.7K	35
Q2 24	$264.0K	35
Q3 24	$252.5K	35
Q4 24	$242.0K	54
Q1 25	$154.5K	54
Q2 25	$135.5K	54
Q4 25	$82.3K	60

Revenue / Employee